Comparing RIT Capital Partners & Glaxosmithkline

This page explains how RIT Capital Partners compares with Glaxosmithkline

In terms of market cap, RIT Capital Partners is 26.15 times lesser than Glaxosmithkline, and each share in RIT Capital Partners is the equivalent to 1.06 shares in Glaxosmithkline.

  RCP   GSK
Price 1,926.00+141.501,784.50
Change 4.00 (0.21%)+1.75-28.00 (-1.54%)
Spread 6.00 (0.312%)+0.2561.00 (0.056%)
Currency GBX GBX
Sector Closed End Investments Medicine and Biotech
Indices UK All-Share, UK 250, UK 350  UK All-Share, UK 350 , UK 100
RIT Capital Partners Intraday Chart
Glaxosmithkline Intraday Chart
RIT Capital Partners 3 Month Chart
Glaxosmithkline 3 Month Chart
What if I invested £1,000?
1 month ago 1 year ago
RCP.LN/A N/A N/A N/A N/A
GSK.LN/A N/A N/A N/A N/A
  RCP   GSK
Shares in Issue 144,470,772   4,078,024,048
Market Capitalisation £2,782,507,069   £72,772,339,137
52 Week High 2,030.00   1,820.00
52 Week Low 1,698.00   1,302.60